VOLUME 13 | NUMBER 6 | JUNE 2010 nature neurOSCIenCe a r t I C l e S The amygdala is a functionally and structurally heterogeneous complex of nuclei 1 located in the ventro-caudal telencephalon that is important for processing and memory of emotional reactions. On the basis of structural, functional and developmental features, the amygdala is divided into four groups of nuclei and a rostro-medial extension called the extended amygdala that includes the bed nuclei of the stria terminalis (BST) and the substantia innominata 2-4 . In terms of embryological origin, the amygdala consists of two groups of nuclei 5, 6 that arise from pallial 7-10 and subpallial 11-14 compartments, although some amygdaloid nuclei are of mixed developmental origin. The medial amygdaloid nucleus (MeA) that forms the vomeronasal amygdala, along with the posterior-medial cortical amygdaloid nucleus (PMc), express genes that are typical of both telencephalic subdivisions and they receive cells from each component 11, 15, 16 . Moreover, the expression of certain diencephalic genes, such as Orthopedia (Otp) 17, 18 , Single disabled-mind 1 (Sim1) 20 , suggests that some amygdaloid nuclei have a dual prosencephalic origin 14, [21] [22] [23] .
a r t I C l e S
The amygdala is a functionally and structurally heterogeneous complex of nuclei 1 located in the ventro-caudal telencephalon that is important for processing and memory of emotional reactions. On the basis of structural, functional and developmental features, the amygdala is divided into four groups of nuclei and a rostro-medial extension called the extended amygdala that includes the bed nuclei of the stria terminalis (BST) and the substantia innominata [2] [3] [4] . In terms of embryological origin, the amygdala consists of two groups of nuclei 5, 6 that arise from pallial [7] [8] [9] [10] and subpallial [11] [12] [13] [14] compartments, although some amygdaloid nuclei are of mixed developmental origin. The medial amygdaloid nucleus (MeA) that forms the vomeronasal amygdala, along with the posterior-medial cortical amygdaloid nucleus (PMc), express genes that are typical of both telencephalic subdivisions and they receive cells from each component 11, 15, 16 . Moreover, the expression of certain diencephalic genes, such as Orthopedia (Otp) 17, 18 , Single disabled-mind 1 (Sim1) 19 and Brain-2 (Brn2) 20 , suggests that some amygdaloid nuclei have a dual prosencephalic origin 14, [21] [22] [23] .
Otp is a highly conserved gene encoding a homeodomain transcription factor that is specifically associated with the development of the hypothalamus in vertebrates 18, 24 . Otp is essential for the differentiation of neuroendocrine hypothalamic neurons associated with the paraventricular hypothalamic (PVH) and supraoptic nuclei 17, 25, 26 . However, as such neurons are absent from amygdaloid nuclei, Otp might have a different role in this system. It is not clear whether OTPexpressing cells can reach telencephalic structures from their origins in diencephalic germinative zones or whether these cells are originally telencephalic and they simply express OTP once they become independent of the hypothalamus.
We examined the development of the telencephalic OTP-expressing cell population to determine whether cells generated in the hypothalamus colonize the telencephalon. We identified a route of tangential cell migration in which cells expressing OTP transgress the di-telencephalic junction (DTJ). Subsequently, we used different in utero approaches to determine whether OTP expression was necessary for these cells to migrate toward their targets. The cells that migrated along this pathway originated exclusively in the rostrodorsal hypothalamic ventricular zone and were targeted to several amygdaloid nuclei. These diencephalic migratory cells expressed OTP and were spatially related to the stria terminalis. Hypothalamic cells no longer colonized the amygdala when OTP expression was silenced and they failed to migrate along this pathway, as was evident in Otp −/− mice. Our data indicate that some amygdaloid nuclei are composed of a complex mixture of cells of diencephalic-telencephalic origin and identify the migratory pathway followed by hypothalamic neurons to reach these nuclei and a transcription factor that controls this process.
RESULTS

OTP expression during development
Otp is believed to be exclusively involved in the development of the hypothalamic neuroendocrine lineage 27 . We examined the spatiotemporal expression of murine OTP protein during embryonic brain development. We first detected OTP protein at embryonic day 10 (E10) in the ventral diencephalon and in the mantle of the dorsal and ventral hypothalamic areas (Fig. 1a-c) . These domains probably belong to the PVH (Fig. 1b and Supplementary Table 1 ) and the ventro-medial hypothalamic nucleus (VMH; Fig. 1c ), respectively. At E11, a similar pattern of OTP expression was detected in the hypothalamus, together with some labeling at the DTJ (Fig. 1d-g ). Indeed, several OTP-immunoreactive cells were located at the boundary between both vesicles (Fig. 1f,g ), suggesting that cells generated earlier had migrated from the hypothalamus toward the telencephalon. As development progressed, the number of a r t I C l e S OTP-immunoreactive cells increased and a continuous stream of OTP-immunoreactive cells formed a pathway from the hypothalamus to the caudo-ventral telencephalic area at E12 (Fig. 1h-j) . In addition, OTP-immunoreactive cells were evident in the amygdaloid primordia (Fig. 1j) .
The definitive pattern of OTP immunoreactivity was evident at the middle and final stages of embryonic development (Fig. 1k-y) and many OTP-immunoreactive hypothalamic cells at E15 (Fig. 1k-r) persisted until the end of the process (Fig. 1s,t) . These cells were located in the early hypothalamic nuclei, particularly the PVH (Fig. 1l,n,s,t) , the supraoptic nuclei (which probably derives from the ventricular zone of the paraventricular hypothalamic nucleus [28] [29] [30] , vzPVH; Fig. 1n,s) and the VMH (Fig. 1n) . OTP expression in the PVH defined a continuous band of cells that entered the telencephalon (Fig. 1l) , a pattern that persisted throughout development. OTPimmunoreactive cells were also found in the BST, which lies lateral and dorsal to the PVH (Fig. 1k,l,t,u) , and close to the supracapsular nucleus of the BST (BST-sc; Fig. 1l,o-r,v,w) . Finally, OTP expression was evident ventral to the BST-sc, entering the vomeronasal amygdala (Fig. 1m,n,s,x,y) , where we found OTP-immunoreactive cells in the MeA and in the PMc.
OTP was similarly expressed during early postnatal development. However, we did not find OTP in adults, although it was not possible to determine when its expression was shut off in the cells that had been expressing it. Because the number of OTP-immunoreactive cells clearly increased from early stages of embryonic development (Fig. 1a-j) , we carried out birth-dating studies and found that OTPimmunoreactive cell generation was completely finished at E13. Indeed, BrdU cells in the hypothalamic or amygdaloid regions that were generated at E13 did not express OTP at E18 ( Supplementary  Fig. 1 ). Thus, OTP-immunoreactive cells appeared to be generated between E10 and E12.
Characterization of OTP-immunoreactive cells
Otp is associated with the development of diencephalic dopaminergic neurons 28, 31 , although tyrosine hydroxylase immunohistochemistry indicated that the OTP-telencephalic neurons that we identified were not dopaminergic at E18 (Supplementary Fig. 1 ). Furthermore, we examined transgenic GAD-green fluorescent protein (GFP) mice, which express GFP under the control of the Gad1 promoter and in which almost every GABAergic cell expresses GFP. OTP was not colocalized with GFP in GAD-GFP coronal sections at E13 (Supplementary Fig. 1 ) or at E15 (data not shown), indicating that the OTP-expressing cell populations were not GABAergic.
We examined the hormones being expressed in the PVH and found that none of the most commonly expressed hormones in the hypothalamus were expressed by OTP-immunoreactive cells, of the boxes in o and q, respectively. (s-y) OTP expression at E18. OTP expression at mid-hypothalamic levels and in the caudal telencephalon is shown in s. (t-w) OTP expression along BST. t and v are magnifications of the boxes in u and w, respectively. A higher magnification of the box in y is shown in x, showing amygdaloid OTP immunoreactivity. DAPI is shown in blue. Scale bars represent 500 μm (a,d,f,l,n,o,q,u,w,y), 250 μm (s), 200 μm (e,h), 100 μm (g,i,j,v,x) and 50 μm (b,c,p,r,t). BM, basomedial amygdaloid nucleus; CC, cerebral cortex; cp, cerebral peduncle; GP, globus pallidus; HC, hippocampus; HT, hypothalamus; ic, internal capsule; IIIV, third ventricle; OC, olfactory cortex; SO, supraoptic nucleus; st, stria terminalis; T, telencephalon; Th, thalamus. Fig. 1 ). We also examined three specific transcription factors (Foxg1, Meis2 and Zic1) that are expressed in some of the areas that express OTP (hypothalamic and amygdaloid). In Otp +/− embryos, these factors were coexpressed with OTP in the BST and preoptic area ( Fig. 2a-h ), whereas only Foxg1 and Meis2 were coexpressed with OTP in the MeA (Fig. 2a-h and Supplementary Fig. 2 ). Although the neurotransmitter identity of these OTP-expressing amygdaloid cells remained unclear, the OTP-expressing cells in the MeA appeared to be glutamatergic, as the vesicular glutamate transporter vGLUT2 was identified around the nucleus (Fig. 2i-m) .
To define the cell types differentiated from OTP-immunoreactive neuroblasts migrating from the PVH, we electroporated a GFP expression plasmid into the third ventricle of E11 embryos in utero. When these embryos were killed on postnatal day 15 (P15), a heterogeneous population of stellate and bitufted GFP-expressing neurons was identified in the MeA and PMc nuclei. As these neurons were multipolar, radiating several long dendrites with few spines in all directions (Fig. 2n,o) , they are likely to be projecting cells. Furthermore, similar neurons were identified in β-galacotsidase-expressing cells (we used LacZ as a reporter of OTP expression) in MeA of Otp +/− P15 mice injected with Lucifer Yellow (Fig. 2p,q) . We confirmed the existence of these cell types in the amygdaloid nuclei in young adult mice stained by the Golgi method ( Fig. 2r-u) .
Diencephalic cells colonize the telencephalon
Our results suggested that some diencephalic-derived cells migrated toward the telencephalon and are located close to the axonal pathway formed by the stria terminalis (Fig. 1) . We traced the diencephalic cell lineage at E12 by injecting carboxy-fluorescein diacetate (CFDA) dye into the third ventricle in utero, allowing the embryos to survive until E18. We then labeled fixed brains with 1,1′-dioctadecyl-3,3,3′, 3′-tetra-methyl-indocarbocyanine perchlorate (DiI) to reveal the stria terminalis (Supplementary Fig. 3) .
Injections into the third ventricle labeled many diencephalic cells corresponding to thalamic and hypothalamic cells. Another cell population migrated to the level of the BST and BST-sc, indicating that some diencephalic cells colonize these telencephalic nuclei. Moreover, CFDA-labeled cells were found in the stria terminalis. Diencephalic cells were always located medially to the axonal pathway, defining a boundary between the amygdaloid axons and the thalamic region. This medial location was similar to that of the OTP-immunoreactive cells in the BST-sc (Supplementary Fig. 3 ).
Neuronal migration from the vzPVH
To determine the precise origin of the OTPimmunoreactive telencephalic cells, we traced cell populations by labeling them with in utero or exo utero injections. The pattern of OTP expression suggested that migratory cells originated at the level of the PVH (Fig. 1l) and we injected CFDA into the hypothalamic vzPVH at E10 and E11 a r t I C l e S ( Supplementary Fig. 4 ). After 24 h in culture, labeled cells migrated dorsally and followed a tangential path toward more rostral levels. The cells generated early in the vzPVH initially migrated radially to cover the hypothalamic area and then these OTP-immunoreactive cells began migrating toward the dorsal hypothalamic regions. Finally, these cells entered the telencephalon and colonized more rostral territories in the mantle of the medial and caudal ganglionic eminences. Telencephalic cells from the vzPVH that were labeled with tracer resided in areas of OTP expression and they expressed OTP. These data indicate that at least one hypothalamic proliferative region, the vzPVH, gave rise to a telencephalic OTP-immunoreactive population ( Supplementary Fig. 4 ). We used in utero tracer injections and ecographic ultrasound to trace selective diencephalic cell lineages and to define the final destination of the OTP-immunoreactive telencephalic cells. The migration and final location of these cells were studied at the mid-and final stages of embryonic development (E15 and E18; Figs. 3 and 4) . The destination of the vzPVH-generated cells reflected the pattern of OTP expression (Figs. 3a-c and 4a,b) at both stages. The tangential migration revealed the complex telencephalic peak of OTP expression. First, cells settled in the PVH and BST and subsequently populated territories more dorsal to the BST (Figs. 3g,h and 4c-g). Calbindin was abundantly expressed in the BST territory, especially in the BST-sc and PVH, although the vzPVH-generated cells that colonized this area never expressed calbindin (Figs. 3d,e,i and 4g,h). At levels caudal to the injection site, some of the traced cells were associated with the stria terminalis (Figs. 3e,f,i-l and 4h,i), similar to those defined by OTP immunohistochemistry (Fig. 1o-r,v,w) , although these cells did not express calretinin (Figs. 3j and 4i) . The most distant area colonized by diencephalic cells was the vomeronasal amygdala. Labeled cells were found ventral to the course of the stria terminalis, specifically occupying the MeA and PMc nuclei (Figs. 3f,k,l and 4j-o). Notably, diencephalic-generated cells did not colonize other amygdaloid nuclei. Moreover, these migratory cells never expressed the pallial marker Tbr1 (Fig. 4m-o) .
To confirm the diencephalic origin of the OTP-expressing telencephalic cells, we carried out dual labeling with the fluorescent tracers and immunohistochemistry for OTP. Almost all of the diencephalic cells that settled in the telencephalon expressed OTP (Fig. 5) , with a constant colocalization of markers along the entire migratory pathway. Thus, diencephalic migratory cells expressed OTP at the hypothalamic levels ( Fig. 5a-c) , along the caudo-rostral extension of the BST ( Fig. 5d-i ) and in the nuclei of the vomeronasal amygdala ( Fig. 5j-l) . These results indicate that the vzPVH is an important hypothalamic region that gives rise to a tangential migratory cell population that crosses the boundary between prosencephalic vesicles. These early generated diencephalic glutamatergic neurons express OTP.
Neuronal migration from adjacent proliferative zones
When we examined other diencephalic germinative zones, intrauterine tracer injections failed to identify telencephalic colonization. Thus, the vzPVH appeared to be the only germinative diencephalic region contributing to amygdaloid development. Ecographic ultrasonic guided injections of tracers into the most ventral thalamic ventricular region, just above the diencephalic sulcus and the vzPVH, gave rise to some radially migrating cell populations that reached the ventro-lateral thalamic nuclei. The cells following this radial migratory path bordered the thalamic-hypothalamic and thalamictelencephalic boundaries, which were clearly defined by calbindin and OTP expression. As expected, thalamic-derived migratory cells did not cross these boundaries or express OTP (Supplementary Fig. 5) .
Injections into the caudal hypothalamic germinative zone also labeled cells that migrated radially into hypothalamic territories. These cells migrated to settle in hypothalamic domains that are associated with the nigro-striatal pathway and the medial prosencephalic tract. They never migrated toward the amygdaloid nuclei and some of them appeared in the VMH and in the caudal portion of the PVH; however, these cells did not express OTP (Supplementary Fig. 6 ). a r t I C l e S
Neuronal migration from vzPVH lacking OTP expression
We then sought to examine migratory cell mechanisms by analyzing whether OTP might have different effects when strongly expressed in vzPVH-derived cells. We studied the function of OTP by inhibiting its translation with RNA interference (RNAi), transfecting diencephalic cells with a plasmid that encoded a specific RNAi (shRNA + pCAGGS/eGFP). Transfections were carried out by filling the third ventricle with a mixture of the recombinant plasmids and then in utero electroporating the area at E10. We then compared cells that expressed functional plasmids with controls cells that were transfected with a nonspecific vector. OTP expression was downregulated at E18 in cells transfected with Otp shRNA (Fig. 6) . The proportion of cells expressing OTP was reduced to 17.7% of GFP-positive cells in the control embryos. Hypothalamic cells lacking OTP at E10 do not reach their regular location by E18 (Fig. 6 ) and the normal distribution of these cells LG, lateral geniculate nucleus. a r t I C l e S in the brain was altered (n = 4 control mice and 4 silenced mice; Fig. 6b,h ). There was a marked increase in the number of transfected cells that remained at hypothalamic levels (31.72 ± 4.31% versus 71.53 ± 4.08%, P = 0.0026; Fig. 6c,i,p) , which was accompanied by a significant decrease in the number of transfected cells that colonized the BST (24.07 ± 2.05% versus 6.567 ± 1.95%, P = 0.0035: Fig. 6d,j,p) and vomeronasal amygdala (44.21 ± 2.67% versus 21.90 ± 2.15%, P = 0.0029: Fig. 6e,k,f,l,p) . This defective migration notably decreased the number of cells that reached the MeA, an important destination in the control embryos (Fig. 6f,l) . There were more silenced cells at hypothalamic levels (Fig. 6m) and fewer at the telencephalic levels (Fig. 6n,o) , indicating that OTP is necessary for migration toward amygdaloid destinations. GFP-positive cells in the OTP-immunoreactive amygdaloid area in control and silenced embryos might originate from other, secondary electroporation, such as subpallial electroporation. Indeed, the decrease in transfected cells in the BST suggested that the proportion of amygdaloid GFP-positive cells might be overestimated as a result of the inclusion of some subpallial transfected cells. Nevertheless, these data strongly suggest that OTP expression is necessary for the correct migration of diencephalic-derived cells toward telencephalic territories.
We confirmed that silencing OTP expression affected migration and not other processes that might reduce cell number. The transfected hemispheres did not present any substantial variation in cell death when assessed by TUNEL. Moreover, when compared with their contralateral hemispheres, no substantial variation in diencephalic cell death was found in either the short (E11-13) or long term (E10-18; Supplementary Fig. 7 ). In addition, phosphohistone 3 (PH3) immunohistochemistry indicated that silencing OTP expression did not affect proliferation in silenced (84.73 ± 9.04) and nonsilenced diencephalic hemispheres (84.33 ± 9.20 PH3-positive cells, n = 4; Supplementary Fig. 7) . Therefore, the loss of GFP-expressing cells in the telencephalon was not a result of abnormalities in the proliferation of diencephalic cells. These findings suggest that OTP is necessary to drive one or several hypothalamic-generated cell populations toward the telencephalon. In addition, OTP does not appear to take part in other developmental processes, such as proliferation and cell death.
Otp knockout mice
To validate our findings with RNAi silencing, we studied embryos from Otp null mice, in which both Otp alleles have been substituted by the LacZ coding sequence to express the β-galactosidase enzyme 26 . In Otp −/− E15 and E18 embryos, telencephalic β-galactosidase expression was strongly reduced in the supraoptic nuclei, BST, MeA and PMc when compared with the Otp +/− controls (Fig. 7) , concomitant with a disorganization of OTP-expressing cells in the hypothalamus (Fig. 7a-d) . Moreover, these amygdaloid nuclei were smaller in the mutant embryos (Supplementary Fig. 8 ). To better understand these amygdaloid abnormalities, we stained Otp +/− and Otp −/− embryos with antibodies to Tbr1, Lhx, Lhx5 and Lhx6, which are markers for different structures 11, 12, 32, 33 (Fig. 8) . The Lhx5-immunoreactive amygdaloid population was lost in Otp −/− embryos (Fig. 8d-f ,m-r and Supplementary Fig. 9 ). β-galactosidase colocalized with Lhx5 at all the levels of the migratory pathway. The amygdaloid complex did not express Lhx1 at E15 or E18 (Fig. 8j-l and Supplementary Fig. 9 ). Tbr1 expression expanded ventrally in the basomedial amygdaloid nucleus at E15, but not at E18 (Fig. 8b) . However, hypothalamic and telencephalic Lhx6 expression was normal in Otp −/− embryos a r t I C l e S (Fig. 8g-i and Supplementary Fig. 9 ), except for some cells in the BST. The expression patterns of Foxg1, Meis2 and Zic1 at E18 were altered (Supplementary Fig. 2) . The expression of these factors was apparently unaffected in Otp −/− neurons.
Sim1 is a gene related to the neuroendocrine lineage that has a similar role to Otp 27 . The distribution of SIM1 was altered in at least three cell populations in Otp −/− mice ( Fig. 7e-j) . One population, which only expressed OTP, did not reach its amygdaloid destinations (BST, MeA and PMc), whereas a second population, which expressed both OTP and SIM1 and established cells in the BST, was absent in Otp −/− embryos. A third population, which only expressed SIM1 and established cells around the central (CeA) and the basomedial amygdaloid nucleus, was absent in the Otp −/− embryos. However, a population of cells that only expressed SIM1 and that colonized the CeA remained unaffected in the absence of OTP.
We asked whether the OTP-expressing cells associated with the stria terminalis and those that populated the BST-sc are necessary for the growth and guidance of the amygdaloid axons (for example, preventing their erroneous invasion of the thalamus). The stria terminalis in Otp -/-mice formed clearly and completely, with no erroneous invasion of neighboring territories, as determined by DiI tracing (Supplementary Fig. 10 ).
DISCUSSION
We identified a tangential migration of cells that are generated in the diencephalon and that colonize the telencephalic amygdaloid complex. To the best of our knowledge, this is the first description of a neuronal migratory route that crosses the boundaries between different vesicles. We suggest that OTP is a fundamental regulator of this tangential migration. The results of our in vivo short-and long-term studies on whole embryos indicate the three-dimensional migratory route of this migration and suggest a mechanism that governs the migration.
Hypothalamic cells cross the DTJ and colonize the amygdala A general feature of brain development is that neurons originate, migrate and differentiate in a specific encephalic vesicle. We identified a tangential migration from the diencephalic germinative zone to the telencephalic mantle in rodents and found that cells generated in the specific diencephalic germinative zone (vzPVH) specifically target telencephalic amygdaloid nuclei (BST, MeA and PMc). Tangential migration is thought to increase phenotypic variation by allowing progenitors to differentiate in diverse molecular environments. Thus, migration across encephalic vesicle boundaries multiplies the molecular environments available, generating new cell types. Intervesicular tangential migration has been described previously 34 ; a migration from the telencephalic ganglionic eminences colonizes the thalamus in humans. The migratory derivatives of these subpallial structures are well known [34] [35] [36] [37] [38] [39] , although it is believed that no such migration occurs in other mammals, such as primates or rodents. Other examples of diencephalictelencephalic migration have been recently suggested by genetic fate mapping of the Foxb1 cell lineage 40 . Although those data support a migratory route from the dorsal diencephalon (prethalamus) to the medial cerebral cortex, this population has not been fully characterized. A diencephalic-telencephalic relationship similar to the one that we identified has been proposed 41 , although the specific diencephalic origin of the amygdaloid cells could not be confirmed. a r t I C l e S Diencephalic-telencephalic migration implies that some telencephalic nuclei possess cells that originate in the diencephalon. We found that the MeA and PMc have a mixed developmental origin, indicating that the amygdaloid complex is not exclusively telencephalic. Previous studies have distinguished between the two main subdivisions in the amygdala on the basis of the embryonic origin of their cells, with the PMc belonging to the pallial amygdala 7, 8, 10 and the MeA to the subpallial amygdala [11] [12] [13] [14] [15] . Furthermore, the MeA nucleus receives cells from the ganglionic eminences and a GABAergic population from the preoptic area 42 , although it also expresses some pallial genes 10, 33 , suggesting that it also receives cells from the pallium. The cell population that we identified originated in the hypothalamic area and settled in these amygdaloid nuclei, and it was glutamatergic, despite not expressing Tbr1 and not having a pallial origin. In addition, their general morphology and the presence of sparse dendritic spines suggest that these are projecting cells. The complex connections of these nuclei with many areas made it impossible to elucidate the targets of the OTP-expressing amygdaloid population. However, structures formed by cells generated in different areas, which increases developmental complexity, also occurs in structures such as the olfactory cortex 43 , hippocampus or cerebral cortex 40 .
Similarities in the hodology, structure, neuronal morphology and biochemistry between the amygdala, BST and substantia innominata have been found [2] [3] [4] . These latter two structures are thought to belong to the extended amygdala. It is known that the BST and substantia innominata are mainly subpallial in origin, but we found that, similar to the amygdala, they also contained diencephalic cells. These developmental features strongly support the concept of an extended amygdala.
OTP expression is needed for proper amygdaloid development
We found that some amygdaloid cells must express OTP to be able to migrate through the di-telencephalic junction. OTP is important for the differentiation of the neuroendocrine hypothalamic lineage 17, 24, 25, 27 and it has not been proposed to be involved in migration. Furthermore, there is no information about the telencephalic population in the Otp -/-mice, although we found that these cells required OTP to migrate across this brain boundary and for the correct formation of the MeA and PMc, as shown by the lack of Lhx5, marker for several amygdaloid a r t I C l e S structures 11, 12, 32, 33 , in the Otp -/-mice. These data suggest that may OTP directly or indirectly regulate Lhx5 expression. Sim1 is another gene that regulates the neuroendocrine lineage 27 and OTP and SIM1 share a similar distribution in the telencephalic population. Both factors can be expressed independently in the same cell and knockout of one gene does not affect the expression of the other 17, 44 . Indeed, the telencephalic SIM1 expression remains unaltered in absence of OTP 17 . However, although a SIM1 population exists that is not affected by the absence of OTP, another two populations that expressed SIM1 in the amygdaloid area were altered by the absence of OTP. One such population also expressed OTP and could be related to a small Lhx5-immunoreactive group of cells at the basomedial amygdaloid nucleus, but the other population, although modified in absence of OTP, did not express OTP, suggesting that a population of OTP-expressing cells is directly involved in the migration of another cell population that only expresses SIM1. This absence of SIM1 at the basomedial amygdaloid nucleus could be related to the transient increase of the Tbr1 labeling.
Although the expression of OTP is relevant in the development of the amygdaloid complex, this transcription factor is not necessary for the correct formation of the stria terminalis. The growth of the stria terminalis was associated with several cell groups belonging to the BST and BST-sc and the OTP-expressing population of these nuclei was not involved in stria terminalis development, but we do not discard the possibility that other populations exist in these nuclei that are directly involved in stria terminalis formation.
Our results suggest a previously unknown migratory route in which tangentially migratory cells settle in distinct encephalic vesicles. Mixed developmental origins would not only increase the phenotypic variability of amygdaloid nuclei, but would make them functionally more complex. Taking into account the fact that migrating neurons frequently transgress theoretical anatomical frontiers, it is necessary to systematically study the cellular relationships between different vesicles to fully unravel the complexity of the brain. In this sense, we propose that the intervesicular migration that we identified is a common feature of all tetrapods, as a telencephalic OTP-immunoreactive cell population has been shown to exist in all animals studied 18 , including the frog, axolotl (amphibian), chicken (bird), mouse and human (mammal).
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/.
Note: Supplementary information is available on the Nature Neuroscience website.
ONLINE METHODS
Animals. Embryos (113) were obtained from wild-type C57 and transgenic GAD67-GFP CD1 pregnant mice (22) and raised in our in-house colony at the Cajal Institute. The day of detection of the vaginal plug was considered to be E0. The Otp knockout mouse was generated and housed in Naples. The Otp +/− (used as controls) and Otp −/− embryos were genotyped as previously described 26 and they were analyzed by immunohistochemistry and in situ hybridization. We used a total of 18 Otp +/− and 19 Otp −/− embryos at E13, E15 and E18. All procedures for animal handling and killing used in this study were in accordance with the European Commission guidelines (86/609/CEE) and they were approved by the animal care and use committee of the Cajal Institute.
Pregnant dams were anesthetized with Equithesin (3 ml per kg of body weight) before surgery to remove the embryos by cesarean section at different developmental stages (E10, E11, E12, E13, E15 and E18) and then they were killed by cervical dislocation. For the embryos, 23 were used for immunohistochemistry studies (20 from C57 and three from GAD67-GFP CD1), ten were injected exo utero with tracers and cultured in toto (two different experiments with five embryos each), 40 were injected with tracers in utero (eight different experiments with five embryos each) and 40 were electroporated in utero (four different experiments with ten embryos each).
whole embryo culture. The experimental procedures for whole embryo culture using an incubator and a roller bottle system were largely based on previously described procedures 36, 45 . Briefly, mouse embryos (E10/11) were removed from the uterus and dissected out in a Petri dish containing Hank's balanced solution at 37 °C under sterile conditions. While maintaining the integrity of the vitelline arteries and veins, the yolk sac was partially broken to expose the embryo. Tracers were injected with the aid of a dissecting microscope (Nikon SMZ1500, Nikon) and a pressure device (Picospritzer, General Valve). Subsequently, the injected embryo was transferred to a glass bottle containing 4 ml of culture medium, which was placed in an incubator for 1 d at 35 °C with continuous gassing (95% O 2 , 5% CO 2 ). The culture medium used was heat-inactivated rat serum obtained by centrifugation of blood from the donor animal (three times at 9,414 g for 5 min each). This serum was filtered with Filtropur S 0.45 (Sarstedt) and supplemented with 1 mg ml −1 glucose and antibiotics (penicillin-streptomycin, 100 IU ml −1 , Gibco).
Birth-dating studies. Timed-pregnant mice (E13) were injected with a single intraperitoneal injection (50 mg per kg) of BrdU solution dissolved in sterile 0.1 M Tris-HCl buffer (BrdU, Boehringer Mannhein), 5 d before being killed. Embryos were transcardially perfused with 4% paraformaldehyde (PFA, wt/vol) and postfixed overnight. The brains were cut into 10-μm-thick sections using a cryostat (Leica CM 1900, Leica), and the sections were first incubated in 2 N HCl for 60 min, and then three times (10 min) in 0.1 M borate buffer (pH 8.5) to neutralize the residual acid. Finally, the sections were stained with an antibody to BrdU (0.25 μg ml −1 , Roche Applied Science) that was visualized with Alexaconjugated secondary antibodies.
Intrauterine experiments. Embryos were injected to specifically label newly generated cells or to fill up the third ventricle using an ultrasound guided injection system, VeVo 770 (VisualSonics; Supplementary movie 1 and Supplementary  Fig. 11) . Briefly, E10-12 pregnant mice were anesthetized with isoflurane (Isova vet, ref. 240055, Centauro), the uterine horns were exposed out of the abdominal wall and covered with pre-warmed ultrasound gel (Parker Laboratories). Each embryo was injected with a volume of 100 nl of the dye into the tissue (Supplementary movie 1) or 1-2 μl of the dye or recombinant plasmid solution into the third ventricle. The embryos were then electroporated. After surgery, the antibiotic enrofloxacin (5 mg per kg, Baytril, Bayer) and the anti-inflammatory ketorolac (300 μg per kg, Droal, VITA Laboratories) were administered to the pregnant mice and the injected embryos were allowed to survive until E15 or E18.
Tracers and injections. We employed three different tracers: crystals of DiI (Molecular Probes), 5% aqueous solution (wt/vol) of BDA (3,000 molecular weight, Molecular Probes) and 10 mM solution of carboxyfluorescein diacetate succinimidyl ester in dimethyl sulfoxide (557 molecular weight, Molecular Probes). DiI was employed on fixed tissue, introducing a small crystal into the amygdala to label the stria terminalis. CFDA and BDA were injected into several diencephalic germinative zones.
electroporations and shRnA silencing. Hypothalamic ventricular zone cells were transfected in utero by means of a BTX Electroporator ECM. Electroporation was accomplished by five pulses (50 ms) discharging a 500-μF capacitor charged to 25 V with a sequencing power supply. The voltage pulse was discharged across a pair of platinum round plates (5 mm in diameter). Two different solutions of DNA plasmids were electroporated. The negative control experiment was performed by transfecting a mixture of pCAGGS/eGFP (1 μg μl −1 , kind gift of P. Bovolenta, Cajal Institute) and a control nontarget shRNA (SHC002, 3 μg μl −1 , Sigma). The silencing experiment was performed by transfecting a mixture of pCAGGS/eGFP (1 μg μl −1 ) and the five commercial plasmids designed to silence Otp translation (Mission shRNA-Otp, SHCLNG-NM_011021, 3 μg μl −1 , Sigma).
Immunohistochemistry. Single and dual immunohistochemistry reactions were performed as described previously 45 using the following primary antibodies: mouse antibody to Reelin (Chemicon, MAB5364, Clone G10, 1:1,000), rabbit antibody to calbindin-D28K (Swant, CB38, 1:10,000), rabbit antibody to calretinin antiserum (Swant, 7699/4, 1:2,000), mouse antibody to β-tubulin class III (TuJ1, Chemicon, MAB1637, 1:1,000), rabbit antibody to PH3 (Chemicon, 06-570, 1:1,000) mouse antibody to tyrosine hydroxylase (Chemicon, MAB318, 1:1,000), rabbit antibody to Tbr1 (Chemicon, AB9616, 1:1,000), rat antibody to GFP (Nacalai Tesque, 04404-84, 1:2,000), rabbit antibody to OTP (gift from F. Vaccarino, Yale University, 1:2,000), rabbit antibody to β-galactosidase (Nordic Immunology, Neo-56 Pab, 1:500), chicken antibody to β-galactosidase (Abcam, AB3661, 1:400), rabbit antibody to somatostatin (Zymed, 18-0078, 1:100), rabbit antibody to vGLUT2 (Synaptic Systems, 135403, 1:75), rabbit antibody to Zic1 (Novus Biologicals, NB600-488, 1:600), rabbit antibody to Foxg1 (kindly provided by G. Corte, Genua, 1:1,000), rabbit anti body to Lucifer Yellow (Instituto Cajal, 1:100,000), rabbit antibody to corticotropin-releasing hormone (Abcam, AB8901-100, 1:75), goat antibody to choline acetyltransferase (Millipore, AB144-P, 1:75), mouse antibody to Meis2 (Abnova, H00004212-H01, 1:200), rabbit antibody to Lhx1 (Abcam, AB14554, 1:300), rabbit antibody to Lhx6 (Abcam, AB22885, 1:200), goat antibody to Lhx5 (Santa Cruz Biotechnology, sc-19347, 1:40) and mouse antibody to BrdU (G3G4 IgG1, kappa light chain isotype, Developmental Studies Hybridoma Bank, University of Iowa, 1:2,000). To visualize the incorporation of BrdU, we treated the samples with 2 N HCl for 30 min to make the epitope accessible to the primary antibody.
For secondary antibodies, we used Alexa 568 goat antibody to rabbit IgG (Molecular Probes, A11011, 1:2,000), Alexa 568 antibody to mouse IgG (Molecular Probes, A11004, 1:2,000), Alexa 488 antibody to rat (Molecular Probes, A11034, 1:2,000), Alexa 568 streptavidin (Molecular Probes, S11225, 1:2,000), Alexa 488 streptavidin (Molecular Probes, S11223, 1:2,000) and biotinylated donkey antibody to rabbit (Amersham Pharmacia Biotech, RPN1004, 1:200). The antibody to Lucifer Yellow was recognized with a biotinylated secondary antibody and visualized using a biotin-horseradish peroxidase complex (Amersham Pharmacia Biotech, RPN1051, 1:200) and 3,3′-diaminobenzidine (DAB, Sigma Chemical, D8001) as the chromogen. Immunohistochemistry with the antibody to β-galactosidase was visualized with the Mach4 Universal HRPPolymer Kit (Biocare Medical, M4U534L) using the 3-amino-9-ethylcarbazole chromogen (Sigma Chemical, A5754).
For all antibodies, a series of control sections were stained in which the primary antibody was omitted and no specific staining was seen. The sections were mounted on gelatinized slides and counterstained with 0.002% solution of bisbenzimide in phosphate-buffered saline (Hoechst 33258, Sigma).
Cell death was detected by TUNEL labeling using the In situ Cell Death Detection Kit, AP (Roche Applied Science, 11 684 809 910). Negative and positive controls were assessed for each tissue sample.
In situ hybridization. In situ hybridization was performed as described previously 24, 26, 27 . The probes for Sim1, LacZ, oxytocin, arginine vasopressin, thyrotropin-releasing hormone and growth hormone-releasing hormone 26 were reverse transcription-PCR fragments of 348, 800, 370, 425, 447 and 354 base pairs, respectively. equipment and settings. Injected embryos were fixed in 4% PFA and examined under a fluorescence-dissecting microscope (Leica MZFL-III). The brains were then embedded in agar and 50-μm vibratome sections were obtained in the coronal plane. Fluorescent sections were mounted with a mixture of glycerol
